MedPath

National Heart, Lung, and Blood Institute

National Heart, Lung, and Blood Institute logo
🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Platelet Drug Trial in Coronary Disease Progression

Phase 3
Completed
Conditions
Cardiovascular Diseases
Myocardial Ischemia
Coronary Disease
Heart Diseases
First Posted Date
1999-10-28
Last Posted Date
2013-11-26
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000496

Diffuse Fibrotic Lung Disease

Phase 2
Completed
Conditions
Pulmonary Fibrosis
Sarcoidosis
Lung Diseases
First Posted Date
1999-10-28
Last Posted Date
2013-11-26
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000596

Extracorporeal Support for Respiratory Insufficiency (ECMO)

Phase 3
Completed
Conditions
Lung Diseases
Acute Respiratory Failure
First Posted Date
1999-10-28
Last Posted Date
2013-11-26
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000562

Interruption of Maternal-to-Infant Transmission of Hepatitis B by Means of Hepatitis B Immune Globulin

Phase 3
Completed
Conditions
Hepatitis B
Liver Diseases
Hepatitis, Viral, Human
First Posted Date
1999-10-28
Last Posted Date
2013-11-26
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000580

Coronary Drug Project

Phase 3
Completed
Conditions
Cardiovascular Diseases
Coronary Disease
Myocardial Ischemia
Heart Diseases
Myocardial Infarction
First Posted Date
1999-10-28
Last Posted Date
2013-11-26
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000482

Trial of Antihypertensive Intervention Management

Phase 3
Completed
Conditions
Cardiovascular Diseases
Heart Diseases
Hypertension
Vascular Diseases
First Posted Date
1999-10-28
Last Posted Date
2013-11-26
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000513

Treatment of Hypertension

Phase 3
Completed
Conditions
Cardiovascular Diseases
Heart Diseases
Vascular Diseases
Hypertension
First Posted Date
1999-10-28
Last Posted Date
2013-11-26
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000484

Hypertension Prevention Trial (HPT) Feasibility Study

Phase 2
Completed
Conditions
Hypertension
Heart Diseases
Vascular Diseases
Cardiovascular Diseases
Obesity
First Posted Date
1999-10-28
Last Posted Date
2013-11-26
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000501

Cardiovascular System in Obesity: Effect of Treatment

Phase 2
Completed
Conditions
Heart Diseases
Vascular Diseases
Obesity
First Posted Date
1999-10-28
Last Posted Date
2013-11-26
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000506

Enhancing Recovery in Coronary Heart Disease (ENRICHD) Patients

Phase 3
Completed
Conditions
Heart Diseases
Myocardial Ischemia
Depression
Cardiovascular Diseases
Myocardial Infarction
Coronary Disease
First Posted Date
1999-10-28
Last Posted Date
2016-04-14
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Registration Number
NCT00000557
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy